ArticleiScience2026

MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway.

Hengyu Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.